In PC cell lines with complete allelic PTEN loss, modulating tumor chemerin levels did not result in changes in PD-L1 expression by the tumor; however, chemerin may recruit immune effector cells into the tumor microenvironment, still having benefits in outcomes [107]. Here, RARRES2 is linked to neoplasm.